TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from EBOS Group Limited ( (AU:EBO) ).
EBOS Group Limited has disclosed a significant acquisition of shares by its director, Tracey Leigh Batten. Batten increased her holding from 1,772 to 4,500 ordinary shares through a market purchase, reflecting a substantial investment in the company. This transaction, valued at NZD 77,020.61, signifies confidence in the company’s future prospects and may influence stakeholder perceptions positively.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a wide range of products and services across Australasia. The company focuses on the distribution and wholesale of healthcare, medical, and pharmaceutical products, as well as animal care products.
Average Trading Volume: 140,198
Technical Sentiment Signal: Sell
Current Market Cap: A$5.16B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.